Gilead Sciences (GILD) Insider Trading & Ownership $91.84 +0.19 (+0.21%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Gilead Sciences (NASDAQ:GILD) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.29%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$45.59 M Get GILD Insider Trade Alerts Want to know when executives and insiders are buying or selling Gilead Sciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address GILD Insider Buying and Selling by Quarter Gilead Sciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/15/2025Andrew D DickinsonCFOSell2,500$91.35$228,375.00 12/24/2024Marjorie Taylor GreeneU.S. Congress Member (R-GA)Buy$93.95$1,001 - $15,00012/16/2024Andrew D DickinsonCFOSell8,500$91.96$781,660.00 11/29/2024Andrew D DickinsonCFOSell248,645$92.76$23,064,310.20 11/27/2024Merdad ParseyInsiderSell164,211$91.92$15,094,275.12 11/26/2024Jeffrey BluestoneDirectorSell6,788$91.39$620,355.32 11/6/2024Merdad ParseyInsiderSell25,590$91.50$2,341,485.00 10/1/2024Merdad ParseyInsiderSell2,000$83.83$167,660.00 9/12/2024Johanna MercierInsiderSell29,357$83.78$2,459,529.46 8/13/2024Johanna MercierInsiderSell5,490$73.98$406,150.20 7/1/2024Merdad ParseyInsiderSell2,000$68.63$137,260.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 5/10/2024Tommy TubervilleU.S. Congress Member (R-AL)Buy$65.96$1,001 - $15,0005/8/2024Tommy TubervilleU.S. Congress Member (R-AL)Sell$64.92$1,001 - $15,0004/5/2024Tommy TubervilleU.S. Congress Member (R-AL)Buy$69.58$1,001 - $15,0004/3/2024Tommy TubervilleU.S. Congress Member (R-AL)Sell$70.89$1,001 - $15,0004/1/2024Merdad ParseyInsiderSell2,000$72.96$145,920.00 2/28/2024Merdad ParseyInsiderSell2,000$73.18$146,360.00 (Data available from 1/1/2013 forward) GILD Insider Trading Activity - Frequently Asked Questions Who is on Gilead Sciences's Insider Roster? The list of insiders at Gilead Sciences includes Andrew D Dickinson, Brett A Pletcher, Diane E Wilfong, Jeffrey Bluestone, Johanna Mercier, and Merdad Parsey. Learn more on insiders at GILD. What percentage of Gilead Sciences stock is owned by insiders? 0.29% of Gilead Sciences stock is owned by insiders. Learn more on GILD's insider holdings. Which Gilead Sciences insiders have been selling company stock? The following insiders have sold GILD shares in the last 24 months: Andrew D Dickinson ($25,303,245.20), Jeffrey Bluestone ($620,355.32), Johanna Mercier ($3,568,145.32), and Merdad Parsey ($19,784,811.99). How much insider selling is happening at Gilead Sciences? Insiders have sold a total of 544,419 Gilead Sciences shares in the last 24 months for a total of $49,276,557.83 sold. Which members of congress are trading Gilead Sciences? Marjorie Taylor Greene (R-GA) and Tommy Tuberville (R-AL) have bought shares of Gilead Sciences in the last year totaling $24,000. Tommy Tuberville (R-AL) has sold shares totaling $16,000. Gilead Sciences Key ExecutivesMr. Daniel P. O'Day (Age 60)Chairman & CEO Compensation: $6.99MMr. Andrew D. Dickinson (Age 54)Chief Financial Officer Compensation: $2.66M3 recent tradesMs. Deborah H. Telman (Age 59)Executive VP of Corporate Affairs, General Counsel & Corporate Secretary Compensation: $2.56MMs. Johanna Mercier (Age 54)Chief Commercial Officer Compensation: $3.1M2 recent tradesDr. Merdad V. Parsey M.D. (Age 60)Ph.D., Chief Medical Officer Compensation: $2.79MMs. Sandra Patterson (Age 57)Senior VP, Corporate Controller & Principal Accounting Officer Ms. Jacquie Ross C.F.A.Vice President of Investor RelationsMs. Jyoti K. Mehra (Age 48)Executive Vice President of Human Resources Dr. Linda Slanec Higgins Ph.D. (Age 62)Senior Vice President of Research, Innovation & Portfolio Dr. Rudolf Ertl (Age 78)Senior Vice President of Commercial Operations of Australia, Canada, Europe More Insider Trading Tools from MarketBeat Related Companies AMGN Insider Buying VRTX Insider Buying REGN Insider Buying ALNY Insider Buying BIIB Insider Buying UTHR Insider Buying NBIX Insider Buying INCY Insider Buying BMRN Insider Buying EXAS Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for InvestorsInsiders Are Selling, But These 3 Stocks Are Must-Buys3 Stocks That Wall Street Insiders Can’t Stop Buying This page (NASDAQ:GILD) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementThe #1 Coin Poised to Soar Under Trump Pro-Crypto White House could make this the investment opportunity of...Crypto 101 Media | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gilead Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gilead Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
